BiPASS™ is the first study designed to gain marketing authorization for 68 Ga-PSMA-PET [2] imaging in the pre-biopsy setting. The prospective, open-label Phase 3 trial will enroll 250 patients across ...
Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...
In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy. Published in the July issue of The Journal of ...
MILAN — When added to prostate biopsy, gallium-68 prostate-specific membrane antigen (PSMA)-PET/CT improves detection of clinically significant prostate tumors and helps guide treatment planning, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results